BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Mar 24, 2026; 17(3): 115094
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.115094
Metabolic axis of autophagy: A key player in tumor maintenance and opportunities for therapeutic exploitation
Minal Garg
Minal Garg, Department of Biochemistry and Director, Institute of Advanced Molecular Genetics and Infectious Diseases, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
Author contributions: Garg M conceptualized and wrote the manuscript including designing and creating the figures.
Supported by Indian Council of Medical Research, Government of India, No. 5/3/8/24/2020-ITR.
Conflict-of-interest statement: Author declares no conflict of interest in publishing the manuscript.
Corresponding author: Minal Garg, Full Professor, Department of Biochemistry and Director, Institute of Advanced Molecular Genetics and Infectious Diseases, University of Lucknow, University Road, Lucknow 226007, Uttar Pradesh, India. garg_minal@lkouniv.ac.in
Received: October 9, 2025
Revised: November 10, 2025
Accepted: January 19, 2026
Published online: March 24, 2026
Processing time: 166 Days and 22.1 Hours
Core Tip

Core Tip: Autophagy is an evolutionary conserved catabolic process that ensures cell adaptability under stress conditions and maintains cellular homeostasis. Dysregulation of autophagy supports tumor growth where its paradoxical role (protective and supportive) appears to depend on tumor stage, driver mutations, tissue type and metabolic sensitivity. Production of metabolic fuel sources and extracellular energy in an autophagy dependent manner contribute to autophagic switch. Pharmacological inhibition of autophagy or depletion of core autophagic genes have been significantly shown to impair metabolism and suppress tumor proliferation. Many recent studies argue that disruption of autophagy/core autophagic genes may potentiate the genomic instability under metabolic stress conditions and drive tumor development. Paradoxical change in the functions of autophagy-dependent metabolic crosstalk in tumor maintenance and disease aggressiveness emphasizes the therapeutic exploitation of supplemental approaches.